These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism. Paschke R Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():129-32. PubMed ID: 8981020 [TBL] [Abstract][Full Text] [Related]
6. Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters. Holzapfel HP; Führer D; Wonerow P; Weinland G; Scherbaum WA; Paschke R J Clin Endocrinol Metab; 1997 Dec; 82(12):4229-33. PubMed ID: 9398745 [TBL] [Abstract][Full Text] [Related]
7. Lack of mutations in the TSHr and Gsalpha genes in TSHr antibody negative Graves' disease. Elgadi A; Frisk T; Larsson C; Wallin G; Höög A; Zedenius J; Norgren S Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):516-21. PubMed ID: 16235153 [TBL] [Abstract][Full Text] [Related]
8. [Mutations in the thyrotropin receptor gene in the pathogenesis of toxic thyroid adenomas, toxic goiter nodules and autosomal dominant hyperthyroidism]. Derwahl M Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():25-8. PubMed ID: 10355046 [TBL] [Abstract][Full Text] [Related]
9. Non-hyperfunctioning nodules from multinodular goiters: a minor role in pathogenesis for somatic activating mutations in the TSH-receptor and Gsalpha subunit genes. Derrien C; Sonnet E; Gicquel I; Le Gall JY; Poirier JY; David V; Maugendre D J Endocrinol Invest; 2001 May; 24(5):321-5. PubMed ID: 11407651 [TBL] [Abstract][Full Text] [Related]
10. Mutations in the thyrotropin receptor signal transduction pathway in the hyperfunctioning thyroid nodules from multinodular goiters: a study in the Turkish population. Gozu H; Avsar M; Bircan R; Sahin S; Deyneli O; Cirakoglu B; Akalin S Endocr J; 2005 Oct; 52(5):577-85. PubMed ID: 16284436 [TBL] [Abstract][Full Text] [Related]
11. Autonomously functioning thyroid nodules in a former iodine-deficient area commonly harbor gain-of-function mutations in the thyrotropin signaling pathway. Georgopoulos NA; Sykiotis GP; Sgourou A; Papachatzopoulou A; Markou KB; Kyriazopoulou V; Papavassiliou AG; Vagenakis AG Eur J Endocrinol; 2003 Oct; 149(4):287-92. PubMed ID: 14514342 [TBL] [Abstract][Full Text] [Related]
12. Lack of reported mutations in a Japanese case of toxic multinodular goiter. Hanamitsu M; Takeuchi E; Kitanishi T; Sakurai H; Tanaka H; Kitano H ORL J Otorhinolaryngol Relat Spec; 2002; 64(4):275-7. PubMed ID: 12232474 [TBL] [Abstract][Full Text] [Related]
13. [Non-autoimmune hyperthyroidism and hyperfunctioning thyroid adenomas caused by activating mutation of the thyrotropin receptor]. Kosugi S Nihon Rinsho; 2002 Feb; 60(2):291-6. PubMed ID: 11857916 [TBL] [Abstract][Full Text] [Related]
14. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. Parma J; Duprez L; Van Sande J; Hermans J; Rocmans P; Van Vliet G; Costagliola S; Rodien P; Dumont JE; Vassart G J Clin Endocrinol Metab; 1997 Aug; 82(8):2695-701. PubMed ID: 9253356 [TBL] [Abstract][Full Text] [Related]
15. High prevalence of TSHR/Gsα mutation-negative clonal hot thyroid nodules (HNs) in a Turkish cohort. Sancak S; Jaeschke H; Eren F; Tarcin O; Guellueoglu B; Sen LS; Sever Z; Gozu HI; Bircan R; Akalin S; Paschke R; Eszlinger M Horm Metab Res; 2011 Jul; 43(8):562-8. PubMed ID: 21773967 [TBL] [Abstract][Full Text] [Related]
16. Two novel mutations in the sixth transmembrane segment of the thyrotropin receptor gene causing hyperfunctioning thyroid nodules. Gozu H; Avsar M; Bircan R; Claus M; Sahin S; Sezgin O; Deyneli O; Paschke R; Cirakoglu B; Akalin S Thyroid; 2005 Apr; 15(4):389-97. PubMed ID: 15876166 [TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of toxic thyroid adenomas and nodules: relevance of activating mutations in the TSH-receptor and Gs-alpha gene, the possible role of iodine deficiency and secondary and TSH-independent molecular mechanisms. Derwahl M; Manole D; Sobke A; Broecker M Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S6-9. PubMed ID: 9867188 [TBL] [Abstract][Full Text] [Related]
18. Two autonomous nodules of a patient with multinodular goiter harbor different activating mutations of the thyrotropin receptor gene. Duprez L; Hermans J; Van Sande J; Dumont JE; Vassart G; Parma J J Clin Endocrinol Metab; 1997 Jan; 82(1):306-8. PubMed ID: 8989278 [No Abstract] [Full Text] [Related]
19. Constitutive activation of the Gs alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas. Derwahl M; Hamacher C; Russo D; Broecker M; Manole D; Schatz H; Kopp P; Filetti S J Clin Endocrinol Metab; 1996 May; 81(5):1898-904. PubMed ID: 8626855 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain. Palos-Paz F; Perez-Guerra O; Cameselle-Teijeiro J; Rueda-Chimeno C; Barreiro-Morandeira F; Lado-Abeal J; ; Araujo Vilar D; Argueso R; Barca O; Botana M; Cabezas-Agrícola JM; Catalina P; Dominguez Gerpe L; Fernandez T; Mato A; Nuño A; Penin M; Victoria B Eur J Endocrinol; 2008 Nov; 159(5):623-31. PubMed ID: 18694911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]